Asthma - management

Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma: The INCA Sun randomized clinical trial
Richard Costello, Liam Heaney, Des Murphy, Elaine Machale

European Respiratory Journal Sep 2022, 60 (suppl 66) RCT4446; DOI: 10.1183/13993003.congress-2022.RCT4446
Late Breaking Abstract - DESTINATION: tezepelumab long-term safety and efficacy versus placebo in patients with severe, uncontrolled asthma
Andrew Menzies-Gow, Michael E. Wechsler, Christopher E. Brightling, Stephanie Korn, Artur Bednarczyk, Sandhia Ponnarambil, Gun Almqvist, Kaitlyn Lawson, Scott Caveney, Karin Bowen, Gene Colice

European Respiratory Journal Sep 2022, 60 (suppl 66) OA9002; DOI: 10.1183/13993003.congress-2022.OA9002
A case of excavated pneumopathy after bronchial thermoplasty
M Steger, N Khayath, M Ohana, N Migueres, C Marcot, F De Blay, N Migueres

European Respiratory Journal Sep 2022, 60 (suppl 66) 4216; DOI: 10.1183/13993003.congress-2022.4216
Developing a point of care (POC) breath test to accurately predict asthma exacerbations
V Higgs, H Ahmed, J A Flavier, F Hegarzy

European Respiratory Journal Sep 2022, 60 (suppl 66) 4487; DOI: 10.1183/13993003.congress-2022.4487
Achievement rate and predictive factors of the deep remission to biologics in severe asthma
K Oishi, K Hamada, Y Murata, Y Yamaji, M Asami, N Edakuni, T Hirano, K Matsunaga

European Respiratory Journal Sep 2022, 60 (suppl 66) 4401; DOI: 10.1183/13993003.congress-2022.4401
Carbon footprint of maintenance and reliever therapy (MART) versus maintenance plus SABA (Mx+SABA) regimens for asthma: Results from the healthCARe-Based envirONmental cost of treatment (CARBON) programme
J Bell, E Maslova, P Miller, A Wilkinson, C Janson, R Beasley, M Crooks

European Respiratory Journal Sep 2022, 60 (suppl 66) 4578; DOI: 10.1183/13993003.congress-2022.4578
Patient sentiments on tobacco industry ownership of respiratory therapies: A community survey
R Tal-Singer, M K Paglou, L Walsh, T Deuby, K Hoth, V Gascon, S Hintringer, N Hass, T Winders, L Morgan, B Thomashow, D Mannino

European Respiratory Journal Sep 2022, 60 (suppl 66) 4445; DOI: 10.1183/13993003.congress-2022.4445
A literature review of allergen management in Children with Type 2-high Asthma
M Gray-ffrench, I Sinha, E Abrams, R Fernandes, L Brown

European Respiratory Journal Sep 2022, 60 (suppl 66) 4300; DOI: 10.1183/13993003.congress-2022.4300
Real-world effectiveness (RWE) of dupilumab in reducing healthcare resource utilization among moderate-to-severe asthma patients
A Pawar, M S Blaiss, B D Modena, A H Khan, L De Prado Gómez, Y Zhang, S Siddiqui, J A Jacob-Nara, L De Prado Gomez

European Respiratory Journal Sep 2022, 60 (suppl 66) 4185; DOI: 10.1183/13993003.congress-2022.4185
Prevalence of anxiety and depression in patients with severe Asthma who are receiving biologic therapy
J Watson, C Peach, N Price, J Evans, A Draper, S Ruickbie

European Respiratory Journal Sep 2022, 60 (suppl 66) 4192; DOI: 10.1183/13993003.congress-2022.4192

Main menu

User menu

Search

Asthma - management

Pages

Contact us